Hepatocarcinogenesis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Roles of Interleukin-10 and Transcriptomic Insights into IL-10 Signaling Rewiring. [PDF]
BiomedicinesSolleiro-Villavicencio H +4 more
europepmc +1 more source
MicroRNA-122 as a regulator and biomarker of liver disease. [PDF]
J Mol Med (Berl)Ahmadova S +7 more
europepmc +1 more source
HBx-Associated Reactivation of the IGF2 Locus in Chronic HBV Infection and HBV-Related Hepatocarcinogenesis: Evidence Boundaries and Biomarker Implications. [PDF]
BiomedicinesWu X, Liu J.
europepmc +1 more source
TG221: An Experimental Model for Liver Cancer Prevention and Treatment Approaches. [PDF]
BioTech (Basel)Callegari E +6 more
europepmc +1 more source
Research progress on hepatitis B surface antigen decline and clearance. [PDF]
ILIVERGuo YF, Sun MQ, Zhang YZ, Ji D.
europepmc +1 more source
Neural regulation of tumor progression: implications for hepatocellular carcinoma. [PDF]
Front ImmunolChen Y, Long Z, Zang YS, Wu D.
europepmc +1 more source
Hepatocellular carcinoma and vitamin D metabolism: novel targets and therapeutic strategies. [PDF]
Cell Oncol (Dordr)Gao H, He L, Chen Z, Wang G.
europepmc +1 more source
HBV Integration in Clinical Management of Hepatocellular Carcinoma by Liquid Biopsy.
OncologyLyu X, Chan ZH, Ho DW.
europepmc +1 more source
Dietary polyphenols and hepatocellular carcinoma: protective mechanisms, challenges, and future directions. [PDF]
Discov OncolYang T, Xu W, Yuan B, Peng F.
europepmc +1 more source